OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacogenetics of antipsychotics: Clinical utility and implementation
María J. Arranz, Juliana Salazar, Marta Hernández
Behavioural Brain Research (2020) Vol. 401, pp. 113058-113058
Closed Access | Times Cited: 30
María J. Arranz, Juliana Salazar, Marta Hernández
Behavioural Brain Research (2020) Vol. 401, pp. 113058-113058
Closed Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Cytochrome P450 Enzymes and Drug Metabolism in Humans
Mingzhe Zhao, Jingsong Ma, Mo Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12808-12808
Open Access | Times Cited: 551
Mingzhe Zhao, Jingsong Ma, Mo Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12808-12808
Open Access | Times Cited: 551
A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study
Teuntje A. D. Pelgrim, Alexandra Philipsen, Allan H. Young, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 151-151
Open Access | Times Cited: 7
Teuntje A. D. Pelgrim, Alexandra Philipsen, Allan H. Young, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 151-151
Open Access | Times Cited: 7
Antipsychotic medications and sleep problems in patients with schizophrenia
Erik Cederlöf, Minna Torniainen‐Holm, Heidi Taipale, et al.
Schizophrenia Research (2024) Vol. 267, pp. 230-238
Open Access | Times Cited: 5
Erik Cederlöf, Minna Torniainen‐Holm, Heidi Taipale, et al.
Schizophrenia Research (2024) Vol. 267, pp. 230-238
Open Access | Times Cited: 5
Effect of food components on cytochrome P450 expression and activity
Rosemary Sang, Wenzhao Jiang, Cai Zhang, et al.
Human Nutrition & Metabolism (2025), pp. 200304-200304
Open Access
Rosemary Sang, Wenzhao Jiang, Cai Zhang, et al.
Human Nutrition & Metabolism (2025), pp. 200304-200304
Open Access
Early intervention for people with psychotic disorders
Paddy Power, Ellie Brown, Patrick D. McGorry
Oxford University Press eBooks (2025), pp. 141-160
Closed Access
Paddy Power, Ellie Brown, Patrick D. McGorry
Oxford University Press eBooks (2025), pp. 141-160
Closed Access
Effects of Crocus sativus and its active constituents on cytochrome P450: a review
Pooneh Bathaei, Mohsen Imenshahidi, Nasser Vahdati-Mashhadian, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Pooneh Bathaei, Mohsen Imenshahidi, Nasser Vahdati-Mashhadian, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
A proposal for reducing maximum target doses of drugs for psychosis: Reviewing dose–response literature
James R. O’Neill, Adam Jameson, Samantha L. McLean, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 4, pp. 344-352
Open Access | Times Cited: 2
James R. O’Neill, Adam Jameson, Samantha L. McLean, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 4, pp. 344-352
Open Access | Times Cited: 2
Antipsychotics-Induced Changes in Synaptic Architecture and Functional Connectivity: Translational Implications for Treatment Response and Resistance
Andrea de Bartolomeis, Giuseppe De Simone, Mariateresa Ciccarelli, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3183-3183
Open Access | Times Cited: 9
Andrea de Bartolomeis, Giuseppe De Simone, Mariateresa Ciccarelli, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3183-3183
Open Access | Times Cited: 9
Pharmacogenetics of Long-Term Outcomes of Schizophrenia Spectrum Disorders: The Functional Role of CYP2D6 and CYP2C19
Amrit Sandhu, Elnaz Naderi, Morenika Wijninga, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1354-1354
Open Access | Times Cited: 4
Amrit Sandhu, Elnaz Naderi, Morenika Wijninga, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1354-1354
Open Access | Times Cited: 4
Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study
Adam Jameson, Muhammad Faisal, Beth Fylan, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 4, pp. 382-394
Open Access | Times Cited: 1
Adam Jameson, Muhammad Faisal, Beth Fylan, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 4, pp. 382-394
Open Access | Times Cited: 1
Prescription Pattern and Off-Label Use of Antipsychotics in a Middle Eastern Population
Kholoud Bastaki, Mohammed El Anbari, Suhaila Ghuloum, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 9
Kholoud Bastaki, Mohammed El Anbari, Suhaila Ghuloum, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 9
Ketogenic diet as a metabolic therapy for bipolar disorder: Clinical developments
Brenda Yu, Ruya S. Oz, Shebani Sethi
Journal of Affective Disorders Reports (2022) Vol. 11, pp. 100457-100457
Open Access | Times Cited: 6
Brenda Yu, Ruya S. Oz, Shebani Sethi
Journal of Affective Disorders Reports (2022) Vol. 11, pp. 100457-100457
Open Access | Times Cited: 6
Nurse practitioner educational preparation and confidence related to managing antipsychotic medications and associated drug-induced movement disorders
Shawn P. Gallagher, Lindsay Bouchard
Journal of the American Association of Nurse Practitioners (2023) Vol. 35, Iss. 10, pp. 629-637
Closed Access | Times Cited: 3
Shawn P. Gallagher, Lindsay Bouchard
Journal of the American Association of Nurse Practitioners (2023) Vol. 35, Iss. 10, pp. 629-637
Closed Access | Times Cited: 3
Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine
Estela Sangüesa, Christine Cirujeda, Julia Concha, et al.
Personalized Medicine (2022) Vol. 19, Iss. 3, pp. 181-192
Closed Access | Times Cited: 5
Estela Sangüesa, Christine Cirujeda, Julia Concha, et al.
Personalized Medicine (2022) Vol. 19, Iss. 3, pp. 181-192
Closed Access | Times Cited: 5
Pharmacogenomics in Psychiatric Diseases
Adrijana Kekic
Springer eBooks (2023), pp. 147-185
Closed Access | Times Cited: 2
Adrijana Kekic
Springer eBooks (2023), pp. 147-185
Closed Access | Times Cited: 2
Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments
Marta Hernández, Natàlia Cullell, Marc Cendrós, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 244-244
Open Access
Marta Hernández, Natàlia Cullell, Marc Cendrós, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 244-244
Open Access
Into a Deeper Understanding of CYP2D6’s Role in Risperidone Monotherapy and the Potential Side Effects in Schizophrenia Spectrum Disorders
Mariana Bondrescu, Liana Dehelean, Simona Sorina Farcaş, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6350-6350
Open Access
Mariana Bondrescu, Liana Dehelean, Simona Sorina Farcaş, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6350-6350
Open Access
Normalising the Implementation of Pharmacogenomic (PGx) Testing in Adult Mental Health Settings: A Theory-Based Systematic Review
Adam Jameson, Justine Tomlinson, Kristina Medlinskiene, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 10, pp. 1032-1032
Open Access
Adam Jameson, Justine Tomlinson, Kristina Medlinskiene, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 10, pp. 1032-1032
Open Access
Improving the efficacy of combinatorial pharmacogenetic testing in schizophrenia therapy in China: a meta-analysis
Xiaohu Xie, Dingding Zhuang, Houxian Ouyang, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Xiaohu Xie, Dingding Zhuang, Houxian Ouyang, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Therapeutic Implications of Recent Genomic Discoveries in Schizophrenia
Steven J. Clapcote
Royal Society of Chemistry eBooks (2024), pp. 225-241
Closed Access
Steven J. Clapcote
Royal Society of Chemistry eBooks (2024), pp. 225-241
Closed Access
Selected Genetic Polymorphisms in Psychiatry
Aneta Bednářová, Ivan Dóci, Slávka Dubinská, et al.
(2024), pp. 1-28
Closed Access
Aneta Bednářová, Ivan Dóci, Slávka Dubinská, et al.
(2024), pp. 1-28
Closed Access
Review of Pharmacogenomics of Psychiatric Comorbidities in Autism Spectrum Disorder
Aida Álvarez, Valentín Bote, Cristina Lamborena, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 14, pp. 781-791
Closed Access | Times Cited: 1
Aida Álvarez, Valentín Bote, Cristina Lamborena, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 14, pp. 781-791
Closed Access | Times Cited: 1
Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data
Albert Martínez-Pinteño, Patricia Gassó, L. Prohens, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 3
Albert Martínez-Pinteño, Patricia Gassó, L. Prohens, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 3
The use of a low carbohydrate, ketogenic diet in bipolar disorder: systematic review
Brenda Yu, Ruya Ozveren, Shebani Sethi
Research Square (Research Square) (2021)
Open Access | Times Cited: 2
Brenda Yu, Ruya Ozveren, Shebani Sethi
Research Square (Research Square) (2021)
Open Access | Times Cited: 2
Pharmacogenomics and antipsychotics: efficacy and adverse drug reactions
Evangelia Eirini Tsermpini, Tea Terzi, Blanka Kores Plesničar, et al.
Elsevier eBooks (2022), pp. 161-188
Closed Access | Times Cited: 1
Evangelia Eirini Tsermpini, Tea Terzi, Blanka Kores Plesničar, et al.
Elsevier eBooks (2022), pp. 161-188
Closed Access | Times Cited: 1
